J Korean Ophthalmol Soc.  2004 Aug;45(8):1397-1401.

ReVersible Change of Vision in Patients Receiving Deferoxamine

Affiliations
  • 1Department of Ophthalmology, Soonchunhyang University College of Medicine, Chunan, Korea. cms3445@hanmir.com

Abstract

PURPOSE
To report 2 cases of acute visual neurotoxicity in patients with paraquat poisoning receiving deferoxamine. METHODS: A 48-year-old woman and a 37-year-old man received intravenous infusion of deferoxamine at 3g/day for 7 days for treatment of paraquat poisoning. They presented with severely impaired visual acuity, generalized constriction of visual field, and decreased amplitude of visual evoked potential. They improved clinically upon drug-withdrawal. CONCLUSIONS: Deferoxamine is an effective agent for treatment of paraquat poisoning, but can cause visual neurotoxicity. We recommend careful regulation of the deferoxamine dosage and serial visual monitoring in patients receiving the drug.

Keyword

Deferoxamine; Paraquat; Visual neurotoxicity

MeSH Terms

Adult
Constriction
Deferoxamine*
Evoked Potentials, Visual
Female
Humans
Infusions, Intravenous
Middle Aged
Paraquat
Poisoning
Visual Acuity
Visual Fields
Deferoxamine
Paraquat
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr